SBC Medical Group to acquire Waqoo via tender offer; CEO selling 26.6% stake at discounted price

SBC Medical Group Holdings Inc

SBCMG to tender for up to 575,000 Waqoo shares at JPY 1,900 each; period Nov 14–Dec 12, 2025.
CEO Yoshiyuki Aikawa to sell his 989,802 shares (26.58%) off-market at JPY 1,445 per share, a discount to tender price.
Post-transaction, Waqoo will become a consolidated subsidiary of SBC Medical Group.
SBCMG currently holds 9.49% of Waqoo; combined with CEO's stake, effective control exceeds 36%.
Strategic rationale: integrate Waqoo's R&D in AGA, orthopedics, skincare, and regenerative medicine.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.